Why parents consider SLIT for school‑age kids

Sublingual immunotherapy (SLIT) helps retrain a child’s immune system to become tolerant to environmental allergens. In the U.S., SLIT is available as FDA‑approved tablets for specific allergens and as physician‑guided liquid drops (off‑label). Both aim for durable relief beyond day‑to‑day medicines. Cochrane‑level reviews and U.S. specialty guidelines support SLIT’s efficacy and safety when used appropriately.

Age indications, allergens covered, and when to start (tablets)

Below are the label‑accurate pediatric ages, allergens, and key first‑dose requirements for SLIT tablets used in the United States.

Tablet (brand)	FDA‑approved ages	Allergen(s) treated	When to start	First‑dose rule	Epinephrine requirement
Grastek (timothy grass)	5–65 years	Timothy grass and cross‑reactive grasses	≥12 weeks before grass season; continue through season	First dose in a healthcare setting with ≥30‑min observation	Prescribe and train on auto‑injectable epinephrine
Oralair (5‑grass mix)	5–65 years	Sweet vernal, orchard, perennial rye, timothy, Kentucky blue	~4 months before grass season; continue through season	First dose supervised with ≥30‑min observation	Prescribe and train on auto‑injectable epinephrine
Ragwitek (short ragweed)	5–65 years	Short ragweed	≥12 weeks before ragweed season; continue through season	First dose supervised with ≥30‑min observation	Prescribe and train on auto‑injectable epinephrine
Odactra (house dust mite)	5–65 years	Dermatophagoides farinae & pteronyssinus	Start any time; taken year‑round	First dose supervised with ≥30‑min observation	Prescribe and train on auto‑injectable epinephrine

Sources: FDA/DailyMed labels and FDA announcements; AAAAI patient education (for perennial timing context).

First dose: what your child and you should expect (tablets)

• Location and observation: The first tablet dose is given in a clinic by a clinician experienced in allergic diseases. Your child is observed for at least 30 minutes for severe local or systemic reactions. If tolerated, dosing continues at home once daily.

• Technique: Tablet is placed under the tongue, allowed to dissolve fully; avoid swallowing for about 1 minute and no food/drink for 5 minutes afterward. Caregivers should supervise children for home doses.

• Common early effects: Mouth or ear itching, throat irritation, tongue/mouth swelling or tingling—usually mild and transient. Contact your clinician if symptoms escalate or persist.

Epinephrine training for families

• Your prescriber must provide an epinephrine device (e.g., auto‑injector) and teach recognition of anaphylaxis, device practice with a trainer, and the “inject first, call 911” plan. Keep two devices available at all times.

• Devices and dosing are weight‑based; training covers newer options and technique. Review your action plan annually and after any use.

Safety, contraindications, and temporary holds (tablets)

• Do not start tablets in children with severe, unstable, or uncontrolled asthma; those with prior severe systemic or severe local SLIT reactions; those with a history of eosinophilic esophagitis; or hypersensitivity to excipients. Use caution with beta‑blockers and certain cardiac conditions.

• Pause dosing during active mouth inflammation (ulcers, oral surgery) until healed; contact your clinician if chest pain, trouble swallowing, or ongoing GI symptoms occur.

Allergy drops (custom SLIT) vs tablets for kids: a neutral comparison

Dimension	Drops (custom SLIT; off‑label in U.S.)	Tablets (FDA‑approved SLIT)
Regulatory status	Not FDA‑approved; physician‑directed, widely studied; dosing and extracts vary by pharmacy/clinic.	FDA‑approved products with boxed warnings, Medication Guides, and standardized dosing.
Allergens addressed	Can combine multiple environmental allergens in one plan (useful for polysensitized kids).	One tablet treats one allergen family at a time (grass mix counts as one).
First dose & epinephrine	Practice varies; many clinicians initiate at home with physician guidance; epinephrine often provided as a precaution.	First dose must be supervised in clinic with ≥30‑min observation; epinephrine is prescribed with training.
Evidence & safety	Systematic reviews show efficacy vs placebo; safety profile favorable with mainly local reactions when properly used. Standardization varies across preparations.	Robust RCT programs and labeled guidance; safety profile favorable; rare anaphylaxis risk addressed via supervised first dose and epinephrine.
Convenience & access	100% at‑home dosing; no seasonal start constraints; can match complex allergen profiles.	Daily at‑home after first dose; specific pre‑season start rules for seasonal allergens; one tablet per allergen.

Notes and references: tablets—FDA/DailyMed labels; drops—systematic reviews and U.S. practice guidance; multi‑allergen vs single‑allergen practicality.

What results should families expect?

• Symptom trajectory: Many pediatric patients begin noticing improvement within 4–12+ weeks of consistent SLIT; maximal benefit accrues over months, and disease‑modifying effects are targeted over 3 years of therapy.

• Practical routines: Give the dose at a consistent time, supervise children, and build the habit into morning routines. If a dose is missed, follow the specific product’s restart instructions and call your clinician for gaps beyond a few days.

How Wyndly supports kids (ages 5+)

Wyndly treats environmental allergies for kids 5+ with physician‑directed, at‑home SLIT, including multi‑allergen custom drops, and offers access to SLIT tablets when appropriate. Families start with a CLIA‑certified at‑home test, meet online with a U.S. board‑certified doctor, and receive medicine shipped to their door with 24/7 support. Many patients notice improvement within 4 weeks to 6 months; plans are designed for about 3 years to lock in long‑term relief.

Quick Q&A for parents

• Can my child take tablets if they have asthma? Tablets are contraindicated in severe, unstable, or uncontrolled asthma; discuss stable asthma with your clinician.

• Do tablets replace all allergy meds immediately? No. They are not for immediate relief; short‑term symptom medications may still be used as your child builds tolerance.

• Why carry epinephrine if reactions are rare? Because a severe reaction, while uncommon, can occur; devices and training improve safety for home dosing.

Parent checklist: the first tablet visit

• Confirm allergen and product (Grastek, Oralair, Ragwitek, or Odactra) and your child’s weight‑appropriate epinephrine device.

• Review boxed‑warning counseling; practice with a trainer.

• Dose under the tongue; no food/drink for 5 minutes after.

• Stay for ≥30 minutes of observation; ask when to hold doses (mouth sores, illness, uncontrolled asthma flare).